• Explore /
  • Poster
  • / Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.

Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.

Abstract Poster

Authors

null

Matthew Steven Davids

Dana-Farber Cancer Institute, Boston, MA

Matthew Steven Davids , John Francis Seymour , John F. Gerecitano , Brad S. Kahl , John M. Pagel , William G. Wierda , Mary Ann Anderson , Nikita Rudersdorf , Lori A. Gressick , Nicholas P. Montalvo , Jianning Yang , Ming Zhu , Martin Dunbar , Elisa Cerri , Sari H. Enschede , Rod Humerickhouse , Andrew Warwick Roberts

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Lymphoma

Clinical Trial Registration Number

NCT01328626

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 8522)

DOI

10.1200/jco.2014.32.15_suppl.8522

Abstract #

8522

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Kiyoshi Ando

First Author: Ki Hyun Kim

First Author: Jianxiang Wang

First Author: Connie Lee Batlevi